To investigate the molecular mechanism of T-DM1 resistance, we established T-DM1–resistant clone BT-474/R1-7 from the HER2-positive breast cancer cell line BT-474 following repeated treatment with T-DM1. This evidence concerns the gene ERBB2 and breast cancer.